Insider Trading & Ownership of Julie Andrews

Location
Arlington, TN
Summary
The estimated net worth of Julie Andrews is at least $1,649,802 dollars as of 06 Mar 2026. Julie Andrews is the CFO of Orthofix Medical Inc. and owns shares of Orthofix Medical Inc. (OFIX) stock worth about $1.11M. Julie Andrews is the Director of RxSight, Inc. and owns shares of RxSight, Inc. (RXST) stock worth about $536K.
Signature
/s/ J. Andres Cedron, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Julie Andrews and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Julie Andrews has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,649,802.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Orthofix Medical Inc. ($1,113,833).
  • Past-year value change for that position: -$131,053.

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Julie Andrews

OFIX Forms 3/4/5

Orthofix Medical Inc.

Relationship
Cfo
Holdings value
$1,113,833
Past year net change
-$131,053
Change %
-11%
Report period
04 Mar 2026
RXST Forms 3/4/5

RxSight, Inc.

Relationship
Director
Holdings value
$535,969
Past year net change
Change %
Report period
03 Jun 2025

Insider Transactions Reported by Julie Andrews:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .